These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7459853)

  • 1. Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells.
    Teicher BA; Kowal CD; Kennedy KA; Sartorelli AC
    Cancer Res; 1981 Mar; 41(3):1096-9. PubMed ID: 7459853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemopotentiation of mitomycin C cytotoxicity in vitro by platinum complexes.
    Teicher BA; Gunner LJ; Roach JA
    Br J Cancer; 1985 Dec; 52(6):833-9. PubMed ID: 3935149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity and DNA lesions produced by mitomycin C and porfiromycin in hypoxic and aerobic EMT6 and Chinese hamster ovary cells.
    Fracasso PM; Sartorelli AC
    Cancer Res; 1986 Aug; 46(8):3939-44. PubMed ID: 3089583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porfiromycin as a bioreductive alkylating agent with selective toxicity to hypoxic EMT6 tumor cells in vivo and in vitro.
    Keyes SR; Rockwell S; Sartorelli AC
    Cancer Res; 1985 Aug; 45(8):3642-5. PubMed ID: 3926306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adducts of mitomycin C and DNA in EMT6 mouse mammary tumor cells: effects of hypoxia and dicumarol on adduct patterns.
    Bizanek R; Chowdary D; Arai H; Kasai M; Hughes CS; Sartorelli AC; Rockwell S; Tomasz M
    Cancer Res; 1993 Nov; 53(21):5127-34. PubMed ID: 7693331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of the metabolism and cytotoxicity of bioreductive alkylating agents by dicoumarol in aerobic and hypoxic murine tumor cells.
    Keyes SR; Rockwell S; Sartorelli AC
    Cancer Res; 1989 Jun; 49(12):3310-3. PubMed ID: 2470504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells.
    Kennedy KA; Rockwell S; Sartorelli AC
    Cancer Res; 1980 Jul; 40(7):2356-60. PubMed ID: 7388797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of mitomycin C cytotoxicity to hypoxic tumor cells by dicoumarol in vivo and in vitro.
    Keyes SR; Rockwell S; Sartorelli AC
    Cancer Res; 1985 Jan; 45(1):213-6. PubMed ID: 2578093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of anthracyclines on oxygenated and hypoxic tumor cells.
    Kennedy KA; Siegfried JM; Sartorelli AC; Tritton TR
    Cancer Res; 1983 Jan; 43(1):54-9. PubMed ID: 6401171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapeutic attack of hypoxic tumor cells by the bioreductive alkylating agent mitomycin C.
    Keyes SR; Heimbrook DC; Fracasso PM; Rockwell S; Sligar SG; Sartorelli AC
    Adv Enzyme Regul; 1985; 23():291-307. PubMed ID: 3934922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hypoxia and acidosis on the cytotoxicity of four platinum complexes at normal and hyperthermic temperatures.
    Herman TS; Teicher BA; Collins LS
    Cancer Res; 1988 May; 48(9):2342-7. PubMed ID: 3356002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the superoxide dismutase inhibitor, diethyldithiocarbamate, on the cytotoxicity of mitomycin antibiotics.
    Pritsos CA; Keyes SR; Sartorelli AC
    Cancer Biochem Biophys; 1989 Oct; 10(4):289-98. PubMed ID: 2559790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of mitomycin C for aerobic and hypoxic cells in vitro and in vivo.
    Rauth AM; Mohindra JK; Tannock IF
    Cancer Res; 1983 Sep; 43(9):4154-8. PubMed ID: 6409398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity and DNA crosslinks produced by mitomycin analogs in aerobic and hypoxic EMT6 cells.
    Keyes SR; Loomis R; DiGiovanna MP; Pritsos CA; Rockwell S; Sartorelli AC
    Cancer Commun; 1991; 3(10-11):351-6. PubMed ID: 1760250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the cytotoxicity of mitomycin C to EMT6 mouse mammary tumor cells by dicoumarol in vitro.
    Rockwell S; Keyes SR; Sartorelli AC
    Cancer Res; 1988 Oct; 48(19):5471-4. PubMed ID: 2458178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction with hyperthermia of tetrachloroplatinum(II)(Nile blue)2 and tetrachloroplatinum(II)(neutral red)2 in EMT6 murine cells and the murine FSaIIC fibrosarcoma.
    Herman TS; Teicher BA; Pfeffer MR; Khandekar VS; Korbut TT
    Cancer Res; 1990 Jul; 50(13):3826-31. PubMed ID: 2354434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1.
    Keyes SR; Fracasso PM; Heimbrook DC; Rockwell S; Sligar SG; Sartorelli AC
    Cancer Res; 1984 Dec; 44(12 Pt 1):5638-43. PubMed ID: 6437671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of BMS-181174 and radiation: studies with EMT6 cells in vitro and in solid tumors.
    Rockwell S; Kelley M
    Radiother Oncol; 1996 Apr; 39(1):65-71. PubMed ID: 8735495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimodality therapy (drug/hyperthermia/radiation) with BCNU or mitomycin C.
    Herman TS; Teicher BA; Holden SA
    Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):375-82. PubMed ID: 2105922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of mitomycin C alone and in combination with X-rays on EMT6 mouse mammary tumors in vivo.
    Rockwell S
    J Natl Cancer Inst; 1983 Oct; 71(4):765-71. PubMed ID: 6413743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.